Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, L.-E
Right arrow Articles by Wei, Q.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, L.-E
Right arrow Articles by Wei, Q.
[Cancer Research 64, 5560-5563, August 15, 2004]
© 2004 American Association for Cancer Research


Advances in Brief

Polymorphisms of DNA Repair Genes and Risk of Glioma

Li-E Wang1, Melissa L. Bondy1,4, Hongbing Shen1, Randa El-Zein1, Kenneth Aldape2, Yumei Cao1, Vinay Pudavalli3, Victor A. Levin3, W. K. Alfred Yung3 and Qingyi Wei1,4

1 Departments of Epidemiology, 2 Pathology, and 3 Neuro-Oncology, The University of Texas M. D. Anderson Cancer Center, and 4 The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas

DNA repair genes play a major role in maintaining genomic stability through different repair pathways that are mediated by cell cycle control genes such as p53. We found previously that glioma patients were susceptible to {gamma}-ray-induced chromosomal breaks, which may be influenced by genetic variation in genes involved in DNA strand breaks, such as XRCC1 in single-strand break repair, XRCC3 and RAD51 in homologous recombination repair, and XRCC7 in nonhomologous end joining double-strand break repair. Therefore, we tested the hypothesis that genetic polymorphisms in XRCC1, XRCC3, RAD51, XRCC7, and p53 were associated with risk of glioma in 309 patients with newly diagnosed glioma and 342 cancer-free control participants frequency matched on age (±5 years), sex, and self-reported ethnicity. We did not find any statistically significant differences in the distributions of XRCC1 Arg399Gln, XRCC3 Thr241Met, RAD51 G135C, and P53 Arg72Pro polymorphisms between the cases and the controls. However, the XRCC7 G6721T variant T allele and TT genotype were more common in the cases (0.668 and 43.4%, respectively) than in the controls (0.613 and 38.9%, respectively), and the differences were statistically significant (P = 0.045 and 0.040, respectively). The adjusted odds ratios were 1.78 (95% confidence interval, 1.08–2.94) and 1.86 (95% confidence interval, 1.12–3.09) for the GT heterozygotes and TT homozygotes, respectively. The combined T variant genotype (GT+TT) was associated with a 1.82-fold increased risk of glioma (95% confidence interval, 1.13–2.93). These results suggest that the T allele may be a risk allele, and this XRCC7 polymorphism may be a marker for the susceptibility to glioma. Larger studies are needed to confirm our findings and unravel the underlying mechanisms.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Leng, C. A. Stidley, R. Willink, A. Bernauer, K. Do, M. A. Picchi, X. Sheng, M. A. Frasco, D. Van Den Berg, F. D. Gilliland, et al.
Double-Strand Break Damage and Associated DNA Repair Genes Predispose Smokers to Gene Methylation
Cancer Res., April 15, 2008; 68(8): 3049 - 3056.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
Y. Liu, H. Zhang, K. Zhou, L. Chen, Z. Xu, Y. Zhong, H. Liu, R. Li, Y. Y. Shugart, Q. Wei, et al.
Tagging SNPs in non-homologous end-joining pathway genes and risk of glioma
Carcinogenesis, September 1, 2007; 28(9): 1906 - 1913.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
J. Lu, L.-E Wang, P. Xiong, E. M. Sturgis, M. R. Spitz, and Q. Wei
172G>T variant in the 5' untranslated region of DNA repair gene RAD51 reduces risk of squamous cell carcinoma of the head and neck and interacts with a P53 codon 72 variant
Carcinogenesis, May 1, 2007; 28(5): 988 - 994.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. M. Costa, P. Ferreira, S. Costa, P. Canedo, P. Oliveira, A. Silva, F. Pardal, G. Suriano, J. C. Machado, J. M. Lopes, et al.
Association between Functional EGF+61 Polymorphism and Glioma Risk
Clin. Cancer Res., May 1, 2007; 13(9): 2621 - 2626.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Semmler, M. Simon, S. Moskau, and M. Linnebank
The Methionine Synthase Polymorphism c.2756A>G Alters Susceptibility to Glioblastoma Multiforme.
Cancer Epidemiol. Biomarkers Prev., November 1, 2006; 15(11): 2314 - 2316.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Bredel, C. Bredel, D. Juric, G. R. Harsh, H. Vogel, L. D. Recht, and B. I. Sikic
High-Resolution Genome-Wide Mapping of Genetic Alterations in Human Glial Brain Tumors
Cancer Res., May 15, 2005; 65(10): 4088 - 4096.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
R. Brem and J. Hall
XRCC1 is required for DNA single-strand break repair in human cells
Nucleic Acids Res., May 2, 2005; 33(8): 2512 - 2520.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.